Resolution of tinea pedis with imiquimod cream 5% in a patient with nodular basal cell carcinoma.

Abstract

A 73-year-old white man with nodular basal cell carcinoma (nBCC) of the toe and interdigital tinea pedis was treated with imiquimod cream 5% once daily for 4 weeks and twice daily for 10 weeks. Results of a posttreatment potassium hydroxide (KOH) preparation and biopsy confirmed clearance of both tinea pedis and nBCC, respectively.

• Authors: Mitchell E Stashower
• Journal: Cutis (Cutis) Vol. 78 Issue 1 Pg. 66-9 (Jul 2006) ISSN: 0011-4162 [Print] United States
• PMID: 16903324 (Publication Type: Case Reports, Journal Article)

Chemical References

• Aminoquinolines
• Antineoplastic Agents
• Imiquimod

Topics

• Administration, Topical
• Aged
• Aminoquinolines (therapeutic use)
• Antineoplastic Agents (therapeutic use)
• Carcinoma, Basal Cell (complications, drug therapy)
• Humans
• Imiquimod
• Male
• Skin Neoplasms (complications, drug therapy)
• Tinea Pedis (complications, drug therapy)
• Toes